Reaction
Testicular Disorder reporting signals
As of the last recalculation, Testicular Disorder appears in 1,003 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is FINASTERIDE (PRR 64.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Finasteride | 159 | 64.8 | 65.0 |
| Bleomycin Sulfate | 15 | 30.6 | 30.6 |
| Umeclidinium | 12 | 28.1 | 28.2 |
| Atomoxetine Hydrochloride | 30 | 26.9 | 27.0 |
| Sildenafil Citrate | 109 | 19.8 | 19.8 |
| Testosterone Cypionate | 7 | 16.4 | 16.4 |
| Gemcitabine | 15 | 8.0 | 8.0 |
| Enzalutamide | 20 | 7.2 | 7.2 |
| Leuprolide Acetate | 23 | 6.3 | 6.3 |
| Relugolix | 5 | 4.4 | 4.4 |
| Palivizumab | 3 | 4.1 | 4.1 |